Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2018New England Journal of MedicineOpen Access

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing

View Full Paper
Ask AI
Bookmark
Share

Authors

GTGenomes Project Consortium Cryptic And TheJohn Radcliffe Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Genomes Project Consortium Cryptic And The (2018) studied this question.

synapsesocial.com/papers/69deefda7702a00918b0d367https://doi.org/10.1056/nejmoa1800474
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study2016 · 34 citations
  2. 2Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations2013 · 210 citations
  3. 3The Sequence Alignment/Map format and SAMtools2009 · 69,282 citations
  4. 4Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations1997 · 340 citations
  5. 5Transmission of Extensively Drug-Resistant Tuberculosis in South Africa2017 · 296 citations